Feature|Articles|October 8, 2023
- Pharmaceutical Executive: October 2023
- Volume 43
- Issue 10
Pharmaceutical Executive, October 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive October 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 3 years ago
A Blueprint for Balancealmost 3 years ago
Biopharma Stock Check: Market Review and Outlookalmost 3 years ago
Securing the Safety Net in Drug Access and Supportalmost 3 years ago
Obesity Drugs in the Payer Market: What to Expectalmost 3 years ago
Boosting Clinical Trials and Patient Access with Payer Insightsalmost 3 years ago
Are We Close to a Peak in Interest Rates?almost 3 years ago
The Harms of ‘Helicopter Research’ in the Life Sciencesalmost 3 years ago
The Rising Importance of Patient Advocacy Innovations in Asiaalmost 3 years ago
A Fond FarewellAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Pharmaceutical Executive Daily: FDA Approves Lipfendra
3
The Power of Better Questions: How Great Leaders Balance Risk, Growth and Curiosity
4
How Nuvation Bio Manages its Ongoing Clinical Trials
5